Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-025518
Filing Date
2022-07-06
Accepted
2022-07-06 19:25:24
Documents
1
Period of Report
2022-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3215
  Complete submission text file 0000899243-22-025518.txt   4647
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

EIN.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSLATE BIO, INC. 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Cloghessy Paula (Reporting) CIK: 0001744682 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 221070277